Impact of thalidomide therapy on serum ferritin, LDH, liver and spleen size
Our data revealed a significant decline in serum ferritin levels from a mean of 2195 ng/mL µg/L at baseline to 1516 ng/mL at 6th month (p ≤ 0.001), and 528 ng/mL at 30th month (p ≤ 0.001) of thalidomide treatment (Fig. Change in serum ferritin, LDH, spleen and liver size at different time intervals. 